Kohl’s (KSS) reported its fourth quarter results today. Revenue improved 9.2% to $6.78 billion, and profits came in at $468 million, up 86%, primarily due to better handling of inventory along with improved marketing efforts. On an adjusted basis, earnings rose 30% to $1.87 per share.
Comp-store sales saw a stellar growth of 6.3% compared to a decline of 2.2% reported in the prior year period. At the end of fiscal 2017, the retailer has 1,158 stores in the US. Kohl’s Board has declared a dividend of $0.61 per share.
Fiscal 2018 Outlook
The retailer forecasts its 2018 earnings to come in the range of $4.95 to $5.45 per share. Same-store sales growth is expected to be between 0% and 2%. On the capex front, the company expects to spend $700 million in the year, while share repurchases would be in the range of $300 million to $400 million.
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated